Our Clinical Trials Program places participants and their families at the centre of everything we do. Our team is always here to answer questions or concerns and to ensure you feel empowered to make confident, informed decisions every step of the way.
We are currently seeking individuals for a new clinical trial, REMIT iGlarLixi.The purpose of this study is to learn more about early diabetes and whether it can possibly be reversed or put in remission.
This is a 1.5 year long study that includes intensive lifestyle therapy and short-term combination drug therapy. Participants may then be taken off diabetes medications and are followed up by our clinical team. If you or someone you know may be interested in participating in the study, please contact us and we will provide you with more information, including details around eligibility.